6-7580562-C-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_004415.4(DSP):āc.4372C>Gā(p.Arg1458Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00201 in 1,613,990 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004415.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.4372C>G | p.Arg1458Gly | missense_variant | 23/24 | ENST00000379802.8 | NP_004406.2 | |
DSP | NM_001319034.2 | c.4050+322C>G | intron_variant | NP_001305963.1 | ||||
DSP | NM_001008844.3 | c.3582+790C>G | intron_variant | NP_001008844.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.4372C>G | p.Arg1458Gly | missense_variant | 23/24 | 1 | NM_004415.4 | ENSP00000369129.3 | ||
DSP | ENST00000418664.2 | c.3582+790C>G | intron_variant | 1 | ENSP00000396591.2 | |||||
DSP | ENST00000710359.1 | c.4050+322C>G | intron_variant | ENSP00000518230.1 |
Frequencies
GnomAD3 genomes AF: 0.00134 AC: 204AN: 151986Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00174 AC: 437AN: 251254Hom.: 1 AF XY: 0.00153 AC XY: 208AN XY: 135780
GnomAD4 exome AF: 0.00208 AC: 3044AN: 1461886Hom.: 4 Cov.: 32 AF XY: 0.00198 AC XY: 1440AN XY: 727244
GnomAD4 genome AF: 0.00134 AC: 204AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.00126 AC XY: 94AN XY: 74354
ClinVar
Submissions by phenotype
not provided Benign:7
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 20, 2020 | This variant is associated with the following publications: (PMID: 21606396, 21636032, 25163546, 24503780, 25179549, 25661095, 25637381, 23299917, 23861362, 25569433, 25985138, 26332594, 27153395, 27930701, 27435932, 26743238, 24055113, 28600387, 30403697, 33232181) - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Jun 24, 2013 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 27, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | DSP: BP4, BS1, BS2 - |
not specified Uncertain:1Benign:4
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 07, 2017 | p.Arg1458Gly in exon 23 of DSP: This variant is not expected to have clinical si gnificance because it has been identified in 0.36% (41/11544) of Latino and 0.24 % (159/66436) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs28763965). Computational prediction too ls and conservation analysis do not provide strong support for or against an imp act to the protein. - |
Uncertain significance, flagged submission | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Dec 02, 2014 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. We classify this as a variant of uncertain significance, based on the weak case data, presence of another more convincing variant in one of the cases, and the presence in control or general populations samples. The variant has been seen in at least one case of DCM and one case of ARVC. There is no segregation data available. Cox et al (2010) reported the variant in one of 149 probands with ARVC in their Dutch cohort. In the paper it appears that this is the only variant the patient had in the five desmosomal genes sequenced, however in an online database managed by one of the authors it is noted that the patient also carries a nonsense variant in DSP that they consider pathogenic. This is likely the same case included in Kapplinger et al (2011) since both are from a Dutch cohort with the same authors. Pugh et al (2014) observed the variant in one patient in a cohort of 766 patients with "DCM or clinical features consistent with DCM" who had genetic testing performed at the Lab for Molecular Medicine. The patient also carries variant of uncertain significance in TTN, CASQ2, ACTN2, and ABCC9. Both of these groups classified the variant as a variant of uncertain significance. In total the variant has been seen in 26 o f 7973 published controls and individuals from publicly available population datasets. The highest frequency is 2 of 173 individuals within the 1000 genomes dataset. The variant was reported online in 18 of 4300 Caucasian individuals and 4 of 2203 African-American individuals in the NHLBI Exome Sequencing Project dataset (as of April 22nd, 2014). Another variant at the same codon, p.Arg1458Gln, is present in 28 of 4300 Caucasian individuals and 0 of 2203 African-American individual. The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. Note that other variants with strong evidence for pathogenicity have been seen at similar frequencies in this dataset so this does not necessarily rule out pathogenicity (Pan et al 2012). Per the GeneDx report, the variant was observed in 2 of 173 individuals in the 1000 Genomes project and those individuals are Hispanic. The ClinSeq group reported that they observed the variant in 2 of 870 individuals (Ng et al 2013). The variant was not observed in the following laboratory and published control samples: 427 individuals (Kapplinger et al 2011). - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 14, 2020 | Variant summary: DSP c.4372C>G (p.Arg1458Gly) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0017 in 252108 control chromosomes in the gnomAD database, including 1 homozygotes. The observed variant frequency is approximately 173.34 fold of the estimated maximal expected allele frequency for a pathogenic variant in DSP causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is benign. c.4372C>G has been reported in the literature in individuals affected with Arrhythmia, DCM or HCM (Cox_2011, Kapplinger_2011, Pugh_2014, Andreasen_2013, Jaaskelainen_2019). These reports do not provide unequivocal conclusions about association of the variant with Arrhythmia. Co-occurrences with other pathogenic variant(s) have been reported (DSP c.3337C>T, R1113X; CASQ2 c.1090_1091insG, p.Asp364GlyfsX10 ; MYH7 c.3158G>A , p.Arg1053Gln), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. 11 clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments. Based on the evidence outlined above, the variant was classified as benign. - |
Cardiomyopathy Benign:3
Benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Nov 29, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego | Nov 01, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Mar 14, 2018 | - - |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Benign:2
Likely benign, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Oct 01, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | Mar 01, 2024 | - - |
Arrhythmogenic right ventricular cardiomyopathy Uncertain:1
Uncertain significance, flagged submission | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Oct 19, 2015 | - - |
Familial isolated arrhythmogenic right ventricular dysplasia Uncertain:1
Uncertain significance, flagged submission | research | CSER _CC_NCGL, University of Washington | Jun 01, 2014 | - - |
Primary familial dilated cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | - | - - |
Left ventricular noncompaction cardiomyopathy Uncertain:1
Uncertain significance, flagged submission | clinical testing | Blueprint Genetics | Jul 10, 2014 | - - |
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Lethal acantholytic epidermolysis bullosa Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 24, 2019 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Woolly hair-skin fragility syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 24, 2019 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Arrhythmogenic right ventricular dysplasia 8 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 24, 2019 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 30, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
DSP-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 13, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at